Fighting 'Nightmare Bacteria': Clin Onc News Report

In a recent report, the CDC discusses the discovery of an "unusual antibiotic resistant" bacteria and strategies to control its spread. A new study reported that the factor Xa inhibitor edoxaban decreased the rate of cancer-associated venous thromboembolism compared with dalteparin. Researchers reported that direct-acting antivirals appear to have a protective effect against liver cancer in patients with hepatitis C. The simplified lymphatic microsurgical preventive healing approach significantly lowered the risk of lymphedema in patients undergoing axillary lymph node dissection, according to a recent analysis. Patients with hepatitis B who take aspirin each day have a lower risk of liver cancer, new research found. https://www.medpagetoday.com/hematologyoncology/othercancers/72269?xid=nl_mpt_DHE_2018-04-12&eun=g721819d0r&pos=2&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%202018-04-12&utm_term=Daily%20Headlines%20-%20Active%20User%20-%20180%20days